We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.76B
AUM Growth
+$561M
Cap. Flow
+$284M
Cap. Flow %
5.97%
Top 10 Hldgs %
29.41%
Holding
449
New
22
Increased
185
Reduced
143
Closed
20

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$15M
2
MRK icon
Merck
MRK
+$11.8M
3
B
Barrick Mining
B
+$10.3M
4
BSX icon
Boston Scientific
BSX
+$9.6M
5
NDSN icon
Nordson
NDSN
+$3.7M

Sector Composition

Rank Sector Weight
1 Technology 22.35%
2 Healthcare 16.01%
3 Financials 11.88%
4 Industrials 10.97%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRMN
251
Garmin
GRMN
$60.2B
$1.25M 0.03%
+12,010
New +$1.23M
FDX icon
252
FedEx
FDX
$76.5B
$1.24M 0.03%
4,999
+131
+3% +$30K
TECH icon
253
Bio-Techne
TECH
$11.2B
$1.24M 0.03%
15,148
-940
-6% -$75.6K
SPYX icon
254
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.87B
$1.21M 0.03%
33,421
AWK icon
255
American Water Works
AWK
$26.7B
$1.18M 0.02%
8,252
-100
-1% -$14.7K
PAYX icon
256
Paychex
PAYX
$42.9B
$1.14M 0.02%
10,190
+336
+3% +$36.7K
BLK icon
257
Blackrock
BLK
$175B
$1.13M 0.02%
1,633
-117
-7% -$78.4K
MO icon
258
Altria Group
MO
$111B
$1.12M 0.02%
24,628
-912
-4% -$41.3K
NDSN icon
259
Nordson
NDSN
$17.2B
$1.11M 0.02%
4,466
-16,570
-79% -$3.7M
SCHX icon
260
Schwab US Large- Cap ETF
SCHX
$74.5B
$1.07M 0.02%
61,383
+2,316
+4% +$38.2K
HSIC icon
261
Henry Schein
HSIC
$9.83B
$1.05M 0.02%
12,991
ASML icon
262
ASML
ASML
$672B
$1.05M 0.02%
1,444
+29
+2% +$19.7K
AFL icon
263
Aflac
AFL
$61.4B
$1.04M 0.02%
14,894
+961
+7% +$64.3K
ETN icon
264
Eaton
ETN
$173B
$999K 0.02%
4,966
+1,587
+47% +$279K
IWS icon
265
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
$988K 0.02%
8,991
TDY icon
266
Teledyne Technologies
TDY
$32.2B
$963K 0.02%
2,343
-1,532
-40% -$632K
ORLY icon
267
O'Reilly Automotive
ORLY
$75.1B
$946K 0.02%
14,850
+75
+0.5% +$4.58K
VRTX icon
268
Vertex Pharmaceuticals
VRTX
$135B
$945K 0.02%
2,685
+13
+0.5% +$4.38K
ZBH icon
269
Zimmer Biomet
ZBH
$18.4B
$939K 0.02%
6,452
TT icon
270
Trane Technologies
TT
$105B
$938K 0.02%
4,905
IWP icon
271
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$937K 0.02%
9,699
+5,627
+138% +$513K
SDY icon
272
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$926K 0.02%
7,552
+318
+4% +$38.8K
LHX icon
273
L3Harris
LHX
$54.4B
$922K 0.02%
4,712
+136
+3% +$26K
IWD icon
274
iShares Russell 1000 Value ETF
IWD
$84.1B
$914K 0.02%
5,793
-265
-4% -$40.5K
IEFA icon
275
iShares Core MSCI EAFE ETF
IEFA
$195B
$913K 0.02%
13,525
+3,336
+33% +$226K

Similar funds

Bradley Foster & Sargent's Q2 2023 Portfolio in Review

As of Q2 2023, Bradley Foster & Sargent held 449 positions worth $4.76B, up 13% from $4.19B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bradley Foster & Sargent deployed $284M of net new capital in Q2 2023, opening 22 new positions and adding to 185 existing holdings. Its largest new stake was Labcorp: 34,403 shares worth $7.13M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Sysco, an estimated $15M trimmed.

  • Bradley Foster & Sargent's largest Q2 2023 buy was Labcorp: 34,403 shares worth $7.13M.
  • Bradley Foster & Sargent added most to Constellation Brands in Q2 2023, an estimated $38.7M increase.
  • Bradley Foster & Sargent's biggest Q2 2023 reduction was Sysco, cutting an estimated $15M.
  • Bradley Foster & Sargent fully exited Matador Resources in Q2 2023, selling an estimated $1.61M.
  • Bradley Foster & Sargent's ten largest holdings make up 29% of its $4.76B portfolio in Q2 2023.
  • Bradley Foster & Sargent opened 22 new positions and closed 20 in Q2 2023.
  • Bradley Foster & Sargent's portfolio value rose 13% quarter-over-quarter to $4.76B.

Based on Bradley Foster & Sargent's 13F filing for Q2 2023, filed 8 Aug 2023.